Wegovy™ (semaglutide 2.4 mg), the first and only once-weekly GLP-1 therapy for weight management, approved in the US
Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved Wegovy™ (the brand ...
Read more
Tag: Wegovy
Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved Wegovy™ (the brand ...
Read more